Glandular fever and Epstein-Barr virus-related polyneuropathy: a life-threatening complication

2020 ◽  
Vol 13 (10) ◽  
pp. e235678
Author(s):  
Colm Brendan Dorris ◽  
Donna Gallagher ◽  
Myles Black

An 18-year-old woman presented with a 1-week history of sore throat, lethargy and fevers. She was subsequently diagnosed with glandular fever and was managed conservatively. Following 1 week of conservative measures, she developed acute upper airway obstruction requiring emergency surgical tracheostomy insertion. Further investigation including electromyography demonstrated multiple cranial nerve neuropathies.

2021 ◽  
Vol 108 (Supplement_9) ◽  
Author(s):  
Catherine McCollum ◽  
Khurram Khan ◽  
Dhruv Sahni ◽  
David Bell ◽  
David Chong

Abstract Background Infectious Mononucleosis (IM) is a common viral illness among adolescents and young adults. While most cases are self-limiting, a small number of patient can develop life threatening complications, such as atraumatic splenic rupture (ASR). This is a rare but serious sequelae, and the commonest cause of associated mortality. While Epstein Barr Virus is commonly associated with IM, concurrent infection of cytomegalovirus (CMV) and EBV is rarely reported.  Both infections are associated with splenomegaly, however this is usually mild and very rarely results in ASR. Methods We present the case of an immunocompetent nineteen year old male who underwent emergency splenectomy for ASR secondary to concurrent EBV and CMV infection. He presented to the Emergency Department with a five hour history of severe, sudden onset left upper quadrant pain preceded by coughing fit. He reported a one year history of incidental splenomegaly and recent positive monospot test in community. Computerised tomography (CT) of abdomen and pelvis confirmed splenic rupture with large haemo-peritoneum and large sub-capsular haematoma. He was haemodynamically unstable and underwent laparotomy and splenectomy. Results Intraoperative findings included two litres of intraperitoneal blood and large spleen with sub-capsular haematoma; approximately seventeen centimetre diameter and weighed nine hundred and seventy grams. Pathology showed features of non-specific lymphoid hyperplasia. Serum virology confirmed high levels of CMV on polymerase chain reaction with low levels of EBV detected. Virology screening was incidentally repeated post discharge and at this time was consistent acute EBV infection. No alternative cause for splenic rupture or pre-existing splenomegaly has been identified. Conclusions The serology results in this case confirm acute CMV infection with most likely concurrent EBV infection. While we cannot confidently identify which virus caused splenic rupture in this case, ASR is a life threatening condition and an important differential in patients presenting with sudden onset LUQ pain and shock. Splenectomy remains the treatment of choice in haemodynamically unstable patients.


2012 ◽  
Vol 4 (1) ◽  
pp. e2012008 ◽  
Author(s):  
Lorenza Torti ◽  
Luigi Maria Larocca ◽  
Giuseppina Massini ◽  
Luciana Teofili

We describe the case of a 17- year old female who developed fatal haemophagocytic syndrome (HPS) one month following acute infection caused by Epstein-Barr virus (EBV). Despite initiation of treatment and reduction of EBV load, laboratory signs of HPS as severe cytopenia, hypofibrinogenemia, hyperferritinemia and hypertriglyceridemia persisted, and the patient died of multiorgan failure. HPS is a rare, but life-threatening complication of EBV infection.


2020 ◽  
Vol 20 (Suppl 2) ◽  
pp. s38-s38
Author(s):  
Faisal Rehman ◽  
Yahya Makkeyah ◽  
Abdul-Aema Buraq ◽  
Georgina Aldous ◽  
Sohail Ahmad

PEDIATRICS ◽  
1978 ◽  
Vol 62 (5) ◽  
pp. 847-849
Author(s):  
Milton J. Reitman ◽  
Heddu J. Zirin ◽  
Charles J. DeAngelis

The clinician must recognize that the Epstein-Barr virus can affect the conduction system of the heart. Therefore, children with infectious mononucleosis who develop bradycardia or hypotension deserve careful cardiac evaluation, including serial ECGs. Pacemaker therapy may be necessary in the treatment of life-threatening bradyarrhymias.


Blood ◽  
2020 ◽  
Vol 135 (11) ◽  
pp. 826-833 ◽  
Author(s):  
Pengpeng Liu ◽  
Xiangyu Pan ◽  
Chong Chen ◽  
Ting Niu ◽  
Xiao Shuai ◽  
...  

Abstract Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a life-threatening hyperinflammatory syndrome triggered by EBV infection. It often becomes relapsed or refractory (r/r), given that etoposide-based regimens cannot effectively clear the virus. r/r EBV-HLH is invariably lethal in adults without allogeneic hematopoietic stem cell transplantation. Here, we performed a retrospective analysis of 7 r/r EBV-HLH patients who were treated with nivolumab on a compassionate-use basis at West China Hospital. All 7 patients tolerated the treatment and 6 responded to it. Five of them achieved and remained in clinical complete remission with a median follow-up of 16 months (range, 11.4-18.9 months). Importantly, both plasma and cellular EBV-DNAs were completely eradicated in 4 patients. Single-cell RNA-sequencing analysis showed that HLH syndrome was associated with hyperactive monocytes/macrophages and ineffective CD8 T cells with a defective activation program. Nivolumab treatment expanded programmed death protein-1–positive T cells and restored the expression of HLH-associated degranulation and costimulatory genes in CD8 T cells. Our data suggest that nivolumab, as a monotherapy, provides a potential cure for r/r EBV-HLH, most likely by restoring a defective anti-EBV response.


2020 ◽  
pp. archdischild-2020-318827
Author(s):  
Jonathan Derrick ◽  
Kate Ryan ◽  
Birgit Konig ◽  
Tammy Rothenberg

Sign in / Sign up

Export Citation Format

Share Document